EICHOR
● Recruiting
Reduced-target Resection After Induction Chemotherapy in Resectable Recurrent Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma · De-escaltion Therapy · Sponsor: Sun Yat-sen University
About this study
The goal of this clinical trial is to compare efficacy of two different resection extension in patients with resectable recurrent nasopharyngeal carcinoma after induction chemotherapy. The main question it aims to answer is that whether tumor regress areas after induction chemotherapy required complete resection. Patients will be randomly assigned to receive reduced-target resection or full-target resection after induction chemotherapy. Researchers will compare these two groups to see if the efficacy of reduced-target resection is not inferior to full-target resection.
This description comes directly from the study's public registry record.
Talk to the study team
Ming-Yuan Chen, MD, PhD · 86-20-8734-3361 · chmingy@mail.sysu.edu.cn
Youping Liu, PhD · 86-13751763276 · liuyoup@sysucc.org.cn
Always discuss trial participation with your own doctor first.
Locations (1)
| Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center | Guangzhou, Guangdong, China | Recruiting |
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05877872